Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240862 · ClinicalTrials.gov registry record
The CREST-2 Registry
A clinical trial of Carotid Artery Diseases, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 8,000
- Enrollment target
- 1
- Study location
NCT02240862 is a study of Carotid Artery Diseases that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 8,000 participants, above the 341-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (2246% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02240862, a study of Carotid Artery Diseases, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 8,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of C2R is to promote the rapid initiation and completion of enrollment in the CREST-2 randomized clinical trial (clinicaltrials.gov ID NCT02089217). Patients with severe symptomatic and asymptomatic carotid artery occlusive disease will be treated with carotid artery stenting (CAS) performed by experienced and skilled interventionists. Interventionists' eligibility will be determined by a multi-specialty Interventional Management Committee (IMC). Patient eligibility will include patients with standard or high-risk, symptomatic or asymptomatic carotid artery disease. Patients will be followed for the occurrence of post-procedural complications. The primary safety and quality endpoint will be the occurrence of any stroke or death within the 30-day period following the stenting procedure. The safety and quality results from C2R will guide selection of interventionists for participation in the CREST-2 randomized clinical trial. Enrollment into C2R will begin in 2015 and continue until publication of the primary results of the randomized trial.
Conditions Studied
Interventions
- DEVICE Carotid Artery Stent
Study Locations (1)
Maryland
- University of Maryland - Administrative Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2015-02 |
| Est. Completion | 2027-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240862
The ClinicalTrials.gov registry entry for NCT02240862 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 341-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (2246% higher). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carotid Artery Diseases appearing as the primary indexed condition, and to 1 intervention - of which Carotid Artery Stent is the first listed.
NCT02240862 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02240862 about?
NCT02240862 is a clinical study titled "The CREST-2 Registry". The objective of C2R is to promote the rapid initiation and completion of enrollment in the CREST-2 randomized clinical trial (clinicaltrials.gov ID NCT02089217). Patients with severe symptomatic and asymptomatic carotid artery occlusive disease will be treated with carotid artery stenting (CAS) per...
What is the current status of trial NCT02240862?
This trial is currently recruiting. The enrollment target is 8,000 participants. The study started on 2015-02. Estimated completion is 2027-01-31.
What conditions does trial NCT02240862 study?
This clinical trial studies the following conditions: Carotid Artery Diseases.
What interventions are being tested in trial NCT02240862?
The interventions under investigation include: Carotid Artery Stent (DEVICE).
Who is sponsoring clinical trial NCT02240862?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02240862 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
RECRUITING · NA
-
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
RECRUITING
-
Assessing Neurocognition After Cerebrovascular Intervention
RECRUITING · NA
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
ACTIVE NOT RECRUITING · NA
-
Study of Carotid Occlusion and Neurocognition
COMPLETED · NA
-
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.